Poland· PL-100405604

Trydonis

A formoterol, glycopyrronium bromid und beclometason product containing beclometasoni dipropionas + formoteroli fumaras + glycopyrronii bromidum, registered in Poland by Chiesi Farmaceutici S.p.A.. The same ATC class is registered in 10 of our 19 countries.

ATC R03AL09

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTrydonisATCR03AL09REGISTER NO.PL-100405604PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Formoterol, glycopyrronium bromid und beclometason is registered in 10 of 19 countries.

Countries holding a registration under ATC R03AL09 (formoterol, glycopyrronium bromid und beclometason), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Formoterol, glycopyrronium bromid und beclometason · ATC R03AL09

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Beclometasoni dipropionas + Formoteroli fumaras + Glycopyrronii bromidum
Manufacturer
Chiesi Farmaceutici S.p.A.
Country
Poland (PL)
ATC code
R03AL09
ATC class
Formoterol, Glycopyrronium bromid und Beclometason
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fb19feba-1dd0-4fd8-9b75-e9e136519696
GET /v1/drugs/fb19feba-1dd0-4fd8-9b75-e9e136519696?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Aerozol inhalacyjny, roztwór",
  "source": "urpl",
  "strength": "87 mcg + 5 mcg + 9 mcg",
  "packaging": "Rp ¦ EU/1/18/1274/002 ¦ 128140\n1 inhalator 120 dawek\nRp ¦ EU/1/18/1274 /001 ¦ 128141\n1 inhalator 60 dawek\nRp ¦ EU/1/ 18/1274 /003 ¦ 128142\n1 inhalator 180 dawek\nRp ¦ EU/1/18/1274/004 ¦ 128143\n2 inhalatory 120 dawek\nRp ¦ EU/1/18/1274/005 ¦ 128144\n3 inhalatory 120 dawek",
  "substance": "Beclometasoni dipropionas 87 mcg + Formoteroli fumaras dihydricus 5 mcg + Glycopyrronii bromidum 9 mcg",
  "common_name": "Beclometasoni dipropionas + Formoteroli fumaras + Glycopyrronii bromidum",
  "pl_product_id": "100405604",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about formoterol, glycopyrronium bromid und beclometason.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.